MC
AMGN icon

Moors & Cabot’s Amgen AMGN Stock Holding History

Moors & Cabot’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-600
Closed -$5.46K – 919
2023
Q4 		$5.46K Buy
+600
New +$163K ﹤0.01% 830
2020
Q1 		– Sell
-500
Closed -$9K – 596
2019
Q4 		$9K Buy
+500
New +$110K ﹤0.01% 605

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Moors & Cabot's AMGN Position: Q2 2026 in Review

Moors & Cabot reduced its Amgen (AMGN) stake by 0.94% in Q2 2026, selling an estimated $48.3K and leaving 14,884 shares worth $5.39M. The position accounts for 0.21% of the portfolio, ranked #96.

Moors & Cabot first reported a position in AMGN in Q1 2014 and has held it in 50 quarters since. The position peaked at $7.4M in Q4 2019. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Moors & Cabot held 14,884 shares of Amgen worth $5.39M as of Q2 2026.
  • Moors & Cabot sold 141 Amgen shares in Q2 2026, an estimated $48.3K.
  • Amgen made up 0.21% of Moors & Cabot's portfolio in Q2 2026, its #96 holding.
  • Moors & Cabot first reported a position in Amgen in Q1 2014 and has held it in 50 quarters since.
  • Moors & Cabot's Amgen position peaked at $7.4M in Q4 2019.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.